250 related articles for article (PubMed ID: 34025654)
1. Attenuated T Cell Responses Are Associated With the Blockade of Cerebral Malaria Development by YOP1-Deficient
Hai L; Shi X; Wang Q
Front Immunol; 2021; 12():642585. PubMed ID: 34025654
[TBL] [Abstract][Full Text] [Related]
2. A Plasmodium homolog of ER tubule-forming proteins is required for parasite virulence.
Shi X; Hai L; Govindasamy K; Gao J; Coppens I; Hu J; Wang Q; Bhanot P
Mol Microbiol; 2020 Sep; 114(3):454-467. PubMed ID: 32432369
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
Blank J; Behrends J; Jacobs T; Schneider BE
Infect Immun; 2016 Feb; 84(2):502-10. PubMed ID: 26644378
[TBL] [Abstract][Full Text] [Related]
4. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
5. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
[TBL] [Abstract][Full Text] [Related]
7. Eosinophils Suppress the Migration of T Cells Into the Brain of
Scheunemann JF; Reichwald JJ; Korir PJ; Kuehlwein JM; Jenster LM; Hammerschmidt-Kamper C; Lewis MD; Klocke K; Borsche M; Schwendt KE; Soun C; Thiebes S; Limmer A; Engel DR; Mueller AK; Hoerauf A; Hübner MP; Schumak B
Front Immunol; 2021; 12():711876. PubMed ID: 34659202
[TBL] [Abstract][Full Text] [Related]
8. CD8
Ghazanfari N; Gregory JL; Devi S; Fernandez-Ruiz D; Beattie L; Mueller SN; Heath WR
J Immunol; 2021 Sep; 207(6):1578-1590. PubMed ID: 34400523
[TBL] [Abstract][Full Text] [Related]
9. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
10. IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.
Villegas-Mendez A; Greig R; Shaw TN; de Souza JB; Gwyer Findlay E; Stumhofer JS; Hafalla JC; Blount DG; Hunter CA; Riley EM; Couper KN
J Immunol; 2012 Jul; 189(2):968-79. PubMed ID: 22723523
[TBL] [Abstract][Full Text] [Related]
11. Perivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral Malaria.
Shaw TN; Stewart-Hutchinson PJ; Strangward P; Dandamudi DB; Coles JA; Villegas-Mendez A; Gallego-Delgado J; van Rooijen N; Zindy E; Rodriguez A; Brewer JM; Couper KN; Dustin ML
PLoS Pathog; 2015; 11(11):e1005210. PubMed ID: 26562533
[TBL] [Abstract][Full Text] [Related]
12. Development of a Novel CD4
Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C θ deficiency increases resistance of C57BL/6J mice to Plasmodium berghei infection-induced cerebral malaria.
Ohayon A; Golenser J; Sinay R; Tamir A; Altman A; Pollack Y; Isakov N
Infect Immun; 2010 Oct; 78(10):4195-205. PubMed ID: 20660606
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CD8
Barrera V; Haley MJ; Strangward P; Attree E; Kamiza S; Seydel KB; Taylor TE; Milner DA; Craig AG; Couper KN
Front Immunol; 2019; 10():1747. PubMed ID: 31396236
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.
Settles EW; Moser LA; Harris TH; Knoll LJ
Infect Immun; 2014 Mar; 82(3):1343-53. PubMed ID: 24396042
[TBL] [Abstract][Full Text] [Related]
16. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA.
Tamura T; Kimura K; Yuda M; Yui K
Infect Immun; 2011 Oct; 79(10):3947-56. PubMed ID: 21807908
[TBL] [Abstract][Full Text] [Related]
17. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.
Miyakoda M; Kimura D; Yuda M; Chinzei Y; Shibata Y; Honma K; Yui K
J Immunol; 2008 Jul; 181(2):1420-8. PubMed ID: 18606696
[TBL] [Abstract][Full Text] [Related]
18. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling.
Claser C; De Souza JB; Thorburn SG; Grau GE; Riley EM; Rénia L; Hafalla JCR
Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396319
[TBL] [Abstract][Full Text] [Related]
19. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis.
Nie CQ; Bernard NJ; Schofield L; Hansen DS
Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053
[TBL] [Abstract][Full Text] [Related]
20. The Glycosylphosphatidylinositol Transamidase Complex Subunit PbGPI16 of Plasmodium berghei Is Important for Inducing Experimental Cerebral Malaria.
Liu Q; Zhao Y; Zheng L; Zhu X; Cui L; Cao Y
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29784863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
